HISOAR

002099
5.872.33% ( -0.14 )
Delay Midday Break: Nov 10, 11:30:00

Current ValuationThe current P/E ratio is -41.49, within the reasonable range, cheaper than 73.29% of the time in the past 5 years, and the industry ranks 200/222, the industry Median 22.63.

-41.49xP/E
Stock price¥6.01Earnings per share¥-0.14

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.63x
016324864

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.63x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688506SHBIOKIN PHARMACEUTICAL
-87.03x15.13%¥110.01B
000661SZCCHT
-70.11x551.28%¥29.71B
300255SZCSBIO
-51.27x--¥18.00B
688837SHEvopoint
-38.42x--¥17.41B
300436SZCosunter
-60.64x--¥12.72B
300363SZPorton
-132.59x13.89%¥12.69B
300006SZLummy
-98.64x--¥11.78B
002099SZHISOAR
-41.49x--¥9.73B
000908SZCSPC Jingfeng
-360.27x--¥9.20B
688505SHFudan-Zhangjiang
-70.68x--¥7.29B
600252SHZhongheng Group
-17.12x--¥7.16B
600129SHTAIJI GROUP
-363.65x127.27%¥7.14B
002737SZSFPM
-49.91x--¥7.03B
600422SHKPC
-23.08x143.48%¥6.59B
688176SHAsieris
-12.09x1.35%¥6.40B
000813SZDEZHAN HEALTHCARE
-15.84x--¥6.14B
002424SZGZBL
-47.17x--¥6.10B
002082SZWBDE
-41.60x--¥6.09B
300267SZER-KANG
-17.36x--¥6.02B
603229SHAusun Pharm
-1,297.54x106.25%¥5.88B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.